Nav: Home

Scientists develop method to quickly enhance immune-system proteins

November 05, 2018

Rice University scientists have found a simple method to attach drugs or other substances to antibodies, the powerful proteins that are central to the body's immune system.

The Rice lab of bioengineer Han Xiao developed a technique called pClick, which uses a cross-linker that snaps to a specific site on antibodies and serves as a bridge to therapeutic molecules or nanomaterials without the need to re-engineer the antibody with harmful chemicals, enzymes or ultraviolet (UV) light.

All of those alternatives are used by companies and researchers to prepare antibodies for conjugation - the process of chemically modifying them.

"But our technology is straightforward, highly efficient and economical," said Xiao, who joined Rice last year with funding from the Cancer Prevention and Research Institute of Texas (CPRIT). "We use native antibodies with no engineering, no enzyme treatment, no chemical treatment, no UV treatment. People have tried to use all these things before to achieve site-specific conjugation. We don't need them."

The research is detailed in the American Chemical Society journal Bioconjugate Chemistry.

Antibodies are dimers, identical proteins that in this case come together in a "Y" shape, and the workhorses of the immune system. Their job is to recognize and bind to pathogens, facilitating the invaders' elimination. Antibodies either roam the blood stream or attach themselves to cells that need protection. Because they are ubiquitous in the body, modifying them is a way to treat disease.

That's not easy, Xiao said. "For the first generation of antibody conjugation, people used targets like lysine or cysteine residues to attach their therapeutic molecules," Xiao said. "But antibodies are so big, and there are so many lysine and cysteine residues, they can never control their positions. Each batch they make of a drug is different."

He said second-generation research focused on site-specific conjugation to place therapeutic drugs at a particular location on the antibody. "That let them optimize the position of the drug, but to do so people needed to know the antibody's sequence and engineer it," Xiao said.

"Our next-generation work addresses two problems," he said. "First, we don't have to engineer antibodies. We use antibodies from the market for direct, site-specific conjugation. Second, we know exactly where our molecule goes on the antibody."

The key to proximity-induced conjugation is using non-canonical amino acids (ncAAs), synthetic hooks that can be made to covalently bind to a specific spot on a protein when it gets close enough (the "p" in pClick stands for proximity). Because antibodies are two-protein dimers, ncAAs bind one to a side and provide two spots for enhancement.

Xiao sees pClick as a general strategy for antibody conjugation by industry and academia. He noted tests to link a side chain protein to human and mouse antibodies conjugated with ncAA showed efficiencies of more than 90 percent. Stability tests showed the antibodies did not significantly degrade after two hours of incubation in human serum.

"The regions of the antibody protein we address are conserved across human and mouse, and we demonstrated that pClick works on both," he said. "This efficiency was a surprise, but it's important for the antibody-drug conjugate field."

Xiao's Rice lab plans to develop pClick for cancer immunotherapy. "We want to achieve different conjugations, from antibody-drug conjugates all the way to antibody-antibody conjugates, where we would mix two antibodies and they would click together," he said.

"We think we can have one antibody target the cancer cell, and the other antibody target the immune cell," Xiao added. "Then the antibodies will bring the cells together."
-end-
Rice graduate student Chenfei Yu and postdoctoral researcher Juan Tang are lead authors of the paper. Co-authors are Rice graduate students Axel Loredo and Yuda Chen and undergraduate Aviva Gordon; and Sung Yun Jung, an assistant professor of biochemistry, and Antrix Jain, a research assistant, of Baylor College of Medicine. Xiao is the Norman Hackerman-Welch Young Investigator and an assistant professor of chemistry.

CPRIT and the Robert A. Welch Foundation supported the research.

Read the abstract at https://pubs.acs.org/doi/10.1021/acs.bioconjchem.8b00680.

This news release can be found online at http://news.rice.edu/2018/11/05/antibodies-get-easy-upgrade-with-pclick/

Follow Rice News and Media Relations via Twitter @RiceUNews.

Related materials:

Xiao Lab: http://xiao.rice.edu/People/hanxiao/hanxiao.html

Department of Chemistry: https://chemistry.rice.edu

Wiess School of Natural Sciences: https://naturalsciences.rice.edu

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,962 undergraduates and 3,027 graduate students, Rice's undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 2 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger's Personal Finance. To read "What they're saying about Rice," go to http://tinyurl.com/RiceUniversityoverview.

Rice University

Related Immune System Articles:

Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
First impressions go a long way in the immune system
An algorithm that predicts the immune response to a pathogen could lead to early diagnosis for such diseases as tuberculosis
Filming how our immune system kill bacteria
To kill bacteria in the blood, our immune system relies on nanomachines that can open deadly holes in their targets.
Putting the break on our immune system's response
Researchers have discovered how a tiny molecule known as miR-132 acts as a 'handbrake' on our immune system -- helping us fight infection.
Decoding the human immune system
For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome.
More Immune System News and Immune System Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...